Lengthy early-development timelines are common across new and emerging biotech companies for a multitude of reasons. Striking the right balance of speed, quality, risk, and investment allows you to shorten timelines and work with efficiency....
Read more ...

Pharmaceutical and biopharmaceutical companies have been extensively using contract research organizations (CROs) to meet their challenging needs in R&D and standard work for several decades. A noticeable shift occurred in outsourcing research...
Read more ...

Virtual pharmaceutical companies often have strong regulatory and clinical teams, but lack the resources needed to address the complexities of the complete product development and commercialization cycle. Partnering with a contract development and...
Read more ...

While liquid-filled hard capsules (LFHCs) have been around for decades, today’s difficult APIs and increased competition have rekindled interest in this versatile and value-added dosage form. LFHCs’ long list of advantages can have a significant...
Read more ...

Executive Summary There are a range of benefits in using an integrated supplier to streamline biologic drug development starting in early phase through clinical and commercial stages. Partnering with one supplier that understands how to best...
Page 1 of 3